RAND's divisions conduct research on a uniquely broad front for clients around the globe.
Most relevant regions
Research
Jan 1, 2001
Quality of life recovery occurs early after radical prostatectomy, except in several domains, which continue to improve beyond 2 years postoperatively
Most large prostate cancers with high serum PSA levels were effectively detected in a prevalence screen.
A number of organisations have developed clinical guidelines, typically at a national level, in order to increase appropriate health care.
Jan 1, 2000
Research Summary
We need valid measures for assessing quality of care for prostate cancer, and we need to understand how variations in quality of care affect treatment outcomes. RAND researchers have built the framework necessary to begin this evaluation.
The authors compare general and disease specific health related quality of life in men undergoing brachytherapy for early stage prostate cancer to those undergoing radical prostatectomy and age matched healthy controls.
Response to an article by Dr. G.W. Chodak and colleagues suggesting that shorter hospital stays following a radical prostatecomy should be considered.
Without a clear survival advantage from one form of treatment, issues such as costs, quality of life, and patient preferences take on more importance.
Patients undergoing surgery or radiation showed different longitudinal profiles of urinary function and bother during first 2 years after treatment.
Jan 1, 1999
During the year after radical prostatectomy for early stage prostate cancer patient quality of life steadily improved.
Older men in a randomly selected, population based sample do not have perfectly normal urinary continence, bowel function or sexual potency.
Cryotherapy has emerged as a promising salvage therapy option for treatment of locally recurrent prostate cancer after initial therapy.